Rocket Pharmaceuticals, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Rocket Pharmaceuticals, Inc. (RCKT) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $788.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2019-11-08
- 2019-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $788.00K.
- 2019-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $987.00K.
- 2019-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $1.19M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $115.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2019-09-30 | $788.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $987.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.19M 10-Q · filed 2019-05-09 |
| 2018-09-30 | $115.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $531.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $641.00K 10-Q · filed 2018-05-11 |
| 2017-09-30 | $102.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $202.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $302.00K 10-Q · filed 2017-05-10 |
| 2016-09-30 | $52.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $107.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $177.00K 10-Q · filed 2016-05-11 |
| 2015-09-30 | $23.00K 10-Q · filed 2015-11-12 |
| 2015-05-31 | $209.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $43.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |